Certain diabetes drugs
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Breast Cancer ~ Swine Flu ~ Lung Cancer ~ Heart attack ~ Pregnancy ~ All Health Topics
Home / Health News / 2008 / August 2008 / August 29, 2008
Certain diabetes drugs double heart failure risk
RSS / Print / Comments
Wake Forest University

Vitamin D protects obese women against endometrial cancer

Now, alternate therapy for adults with poorly controlled asthma

Marriott International Announces Leadership Positions for Asia Pacific, Middle East and Africa

More on Wake Forest University

Heart attack

Watermelon effectively lowers BP

More strokes, fewer heart attacks with carotid stents: Study

Insulin resistance may be linked to stroke risk

More on Heart attack

Health News

Watermelon effectively lowers BP
A pilot study led by food scientists at The Florida State University suggests that watermelon can be an effective natural weapon against prehypertension, a precursor to cardiovascular disease. ANI

Blame your mom for your muffin top or thunder thighs
A new study by an international team of researchers, including Cambridge and Oxford experts, has revealed that our propensity to be apple or pear-shaped is at least partly in our genes. ANI

Blame your mom for your muffin top or thunder thighs
A new study by an international team of researchers, including Cambridge and Oxford experts, has revealed that our propensity to be apple or pear-shaped is at least partly in our genes. ANI

Certain diabetes drugs double heart failure risk

A certain class of oral drugs used to treat type 2 diabetes can double the risk of heart failure in patients, warn a group of group of researchers led by an Indian origin researcher.

Washington, Aug 29 : A certain class of oral drugs used to treat type 2 diabetes can double the risk of heart failure in patients, warn a group of group of researchers led by an Indian origin researcher.

Sonal Singh, assistant professor of internal medicine, and Curt D. Furberg, M.D., Ph.D., professor of public health sciences, from Wake Forest University School of Medicine faculty members have said that thiazolidinediones can exacerbate heart attack risk.

Rosiglitazone and pioglitazone are the two major thiazolidinediones given to control diabetes by lowering blood sugar levels. "We strongly recommend restrictions in the use of thiazolidinediones (the class of drugs) and question the rationale for leaving rosiglitazone on the market," wrote experts.

"At this time, justification for use of thiazolidinediones is very weak to non-existent," they added.

Singh and Furberg said that diabetics have high blood pressure, cholesterol and triglyceride levels, which "further compound their already increased risk of developing ischemic heart disease."

Heart disease and high blood pressure "represent conditions that are major precursors of congestive heart failure."

An analysis of four long-term trials, using rosiglitazone, showed that it doubled heart failure risk among the diabetes patients.

They said that results from three large randomized clinical trials earlier failed to demonstrate that intensive control of blood sugar reduces mortality or events from cardiovascular disease in patients with type 2 diabetes.

ANI

Suggested pages for your additional reading
AndhraNews.net on Facebook






© 2000-2018 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us